8081 Innovation Park Dr
700
Fairfax, VA 22031
3580 Joseph Siewick Dr
401
Fairfax, VA 22033-1764
System Associate Director for Interventional Cardiology and Executive Director of the Cardiac Catheterization Laboratories for Inova
Dr. Behnam N. Tehrani serves as the System Associate Director for Interventional Cardiology and Executive Director of the Cardiac Catheterization Laboratories for Inova. He is also an Assistant Clinical Professor of Medicine at George Washington University and the University of Virginia. His clinical and research interests involve complex coronary, pulmonary and peripheral vascular disease, as well as renal denervation for the management of resistant hypertension.
Dr. Tehrani is involved in clinical trials and registries pertaining to cardiogenic shock and pulmonary embolism. He is a member of Inova Schar Heart and Vascular’s complex high-risk percutaneous coronary intervention, chronic total occlusion, resistant hypertension, cardiogenic shock, pulmonary embolism response team and chronic thromboembolic pulmonary hypertension programs. In line with Inova’s mission and values, he has dedicated his career to the employment of team-based systems of care, using innovative technologies coupled with research and a lifelong commitment to education and learning.
Dr. Tehrani is a nationally recognized leader and serves on national committees in the American College of Cardiology and the Society for Cardiovascular Angiography and Interventions. He has co-authored more than 50 peer-reviewed publications, and his work has been published in Journal of American College of Cardiology (JACC), JACC: Heart Failure, JACC: Cardiovascular Interventions, JAMA Cardiology, Circulation: Heart Failure, and the Journal of the Society for Cardiovascular Angiography and Interventions. He is also a peer reviewer for Journal of American College of Cardiology, Circulation, the European Heart Journal, the American Heart Journal and Catheterization and Cardiovascular Intervention.
Inova introduces a groundbreaking procedure to control resistant high blood pressure (April 2024)
Surviving Cardiogenic Shock: Survival Rates Soar at Inova (April 2019)
A Standardized and Regionalized Network of Care for Cardiogenic Shock, JACC: Heart Failure
Please make note of the following information. This Find a Doctor referral service is sponsored by Inova. It includes Inova employed providers (indicated by the Inova mark and referred to as an "Inova provider") and independent practitioners who have obtained the appropriate medical staff privileges at an Inova facility or care site. Independent practitioners are not Inova employees, agents or representatives of Inova and are solely responsible for their provision of medical care to you. There is no charge or fee to you or for the participating provider for our service.
Patient Reviews
About Patient Comments
The Patient Rating score is an average of all responses to physician related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.